Modeling Clear Cell Sarcomagenesis in the Mouse: Cell of Origin Differentiation State Impacts Tumor Characteristics

Cancer Cell

Volumn 23, Issue 2, 2013, Pages 215-227

  Straessler, Krystal M ^a   Jones, Kevin B ^b   Hu, Hao ^c   Jin, Huifeng ^b   van de Rijn, Matt ^d   Capecchi, Mario R ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRE RECOMBINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CELL DIFFERENTIATION; CHROMOSOME 12; CHROMOSOME 22; CHROMOSOME TRANSLOCATION; CLEAR CELL SARCOMA; CLEAR CELL SARCOMAGENESIS; CONTROLLED STUDY; DEVELOPMENTAL TOXICITY; DNA SEQUENCE; EMBRYO DEVELOPMENT; FETUS; FIBROBLAST; GENE EXPRESSION PROFILING; INTERNAL RIBOSOME ENTRY SITE; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; ONCOGENE; ONCOGENE EWS ATF1; PHENOTYPE; PRIORITY JOURNAL;

EID: 84873595647     PISSN: 15356108     EISSN: 18783686     Source Type: Journal    
DOI: 10.1016/j.ccr.2012.12.019     Document Type: Article

References (48)

1. Antonescu C.R., Tschernyavsky S.J., Woodruff J.M., Jungbluth A.A., Brennan M.F., Ladanyi M. Molecular diagnosis of clear cell sarcoma: detection of EWS-ATF1 and M-MITF transcripts and histopathological and ultrastructural analysis of 12 cases. J. Mol. Diagn. 2002, 4:44-52.
2. Antonescu C.R., Katabi N., Zhang L., Sung Y.S., Seethala R.R., Jordan R.C., Perez-Ordoñez B., Have C., Asa S.L., Leong I.T., et al. EWSR1-ATF1 fusion is a novel and consistent finding in hyalinizing clear-cell carcinoma of salivary gland. Genes Chromosomes Cancer 2011, 50:559-570.
3. Chen G., Folpe A.L., Colby T.V., Sittampalam K., Patey M., Chen M.G., Chan J.K. Angiomatoid fibrous histiocytoma: unusual sites and unusual morphology. Mod. Pathol. 2011, 24:1560-1570.
4. Clancy B.M., Johnson J.D., Lambert A.J., Rezvankhah S., Wong A., Resmini C., Feldman J.L., Leppanen S., Pittman D.D. A gene expression profile for endochondral bone formation: oligonucleotide microarrays establish novel connections between known genes and BMP-2-induced bone formation in mouse quadriceps. Bone 2003, 33:46-63.
5. Claudinot S., Nicolas M., Oshima H., Rochat A., Barrandon Y. Long-term renewal of hair follicles from clonogenic multipotent stem cells. Proc. Natl. Acad. Sci. USA 2005, 102:14677-14682.
6. Covinsky M., Gong S., Rajaram V., Perry A., Pfeifer J. EWS-ATF1 fusion transcripts in gastrointestinal tumors previously diagnosed as malignant melanoma. Hum. Pathol. 2005, 36:74-81.
7. D'Amico F.E., Ruffolo C., Romeo S., Massani M., Dei Tos A.P., Bassi N. Clear cell sarcoma of the ileum: report of a case and review of the literature. Int. J. Surg. Pathol. 2012, 20:401-406.
8. Danielian P.S., Muccino D., Rowitch D.H., Michael S.K., McMahon A.P. Modification of gene activity in mouse embryos in utero by a tamoxifen-inducible form of Cre recombinase. Curr. Biol. 1998, 8:1323-1326.
9. Davis I.J., Kim J.J., Ozsolak F., Widlund H.R., Rozenblatt-Rosen O., Granter S.R., Du J., Fletcher J.A., Denny C.T., Lessnick S.L., et al. Oncogenic MITF dysregulation in clear cell sarcoma: defining the MiT family of human cancers. Cancer Cell 2006, 9:473-484.
10. Dimas K., Tsimplouli C., Anagnostopoulos A.K., Mahaira L., Iliopoulou E., Perez S., Vougas K., Tsangaris G.T. The proteome profile of two cell lines and their xenografts isolated from a patient with clear cell sarcoma (soft tissue melanoma). Cancer Genomics Proteomics 2008, 5:175-237.
11. Durland J.L., Sferlazzo M., Logan M., Burke A.C. Visualizing the lateral somitic frontier in the Prx1Cre transgenic mouse. J. Anat. 2008, 212:590-602.
12. Engleka K.A., Gitler A.D., Zhang M., Zhou D.D., High F.A., Epstein J.A. Insertion of Cre into the Pax3 locus creates a new allele of Splotch and identifies unexpected Pax3 derivatives. Dev. Biol. 2005, 280:396-406.
13. Enzinger F.M. Clear-cell sarcoma of tendons and aponeuroses. An analysis of 21 cases. Cancer 1965, 18:1163-1174.
14. Falconieri G., Bacchi C.E., Luzar B. Cutaneous clear cell sarcoma: report of three cases of a potentially underestimated mimicker of spindle cell melanoma. Am. J. Dermatopathol. 2012, 34:619-625.
15. Fujimura Y., Siddique H., Lee L., Rao V.N., Reddy E.S. EWS-ATF-1 chimeric protein in soft tissue clear cell sarcoma associates with CREB-binding protein and interferes with p53-mediated trans-activation function. Oncogene 2001, 20:6653-6659.
16. Granter S.R., Weilbaecher K.N., Quigley C., Fletcher C.D., Fisher D.E. Clear cell sarcoma shows immunoreactivity for microphthalmia transcription factor: further evidence for melanocytic differentiation. Mod. Pathol. 2001, 14:6-9.
17. Haldar M., Hancock J.D., Coffin C.M., Lessnick S.L., Capecchi M.R. A conditional mouse model of synovial sarcoma: insights into a myogenic origin. Cancer Cell 2007, 11:375-388.
18. Haldar M., Randall R.L., Capecchi M.R. Synovial sarcoma: from genetics to genetic-based animal modeling. Clin. Orthop. Relat. Res. 2008, 466:2156-2167.
19. Haldar M., Hedberg M.L., Hockin M.F., Capecchi M.R. A CreER-based random induction strategy for modeling translocation-associated sarcomas in mice. Cancer Res. 2009, 69:3657-3664.
20. Hantschke M., Mentzel T., Rütten A., Palmedo G., Calonje E., Lazar A.J., Kutzner H. Cutaneous clear cell sarcoma: a clinicopathologic, immunohistochemical, and molecular analysis of 12 cases emphasizing its distinction from dermal melanoma. Am. J. Surg. Pathol. 2010, 34:216-222.
21. Hasson P., Del Buono J., Logan M.P. Tbx5 is dispensable for forelimb outgrowth. Development 2007, 134:85-92.
22. Hocar O., Le Cesne A., Berissi S., Terrier P., Bonvalot S., Vanel D., Auperin A., Le Pechoux C., Bui B., Coindre J.M., Robert C. Clear cell sarcoma (malignant melanoma) of soft parts: a clinicopathologic study of 52 cases. Dermatol. Res. Pract. 2012, 2012:984096.
23. Huang da W., Sherman B.T., Lempicki R.A. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009, 37:1-13.
24. Huang da W., Sherman B.T., Lempicki R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 2009, 4:44-57.
25. Joshi S.K., Hashimoto K., Koni P.A. Induced DNA recombination by Cre recombinase protein transduction. Genesis 2002, 33:48-54.
26. Kawanami A., Matsushita T., Chan Y.Y., Murakami S. Mice expressing GFP and CreER in osteochondro progenitor cells in the periosteum. Biochem. Biophys. Res. Commun. 2009, 386:477-482.
27. Keller C., Capecchi M.R. New genetic tactics to model alveolar rhabdomyosarcoma in the mouse. Cancer Res. 2005, 65:7530-7532.
28. Keller C., Arenkiel B.R., Coffin C.M., El-Bardeesy N., DePinho R.A., Capecchi M.R. Alveolar rhabdomyosarcomas in conditional Pax3:Fkhr mice: cooperativity of Ink4a/ARF and Trp53 loss of function. Genes Dev. 2004, 18:2614-2626.
29. Keller C., Hansen M.S., Coffin C.M., Capecchi M.R. Pax3:Fkhr interferes with embryonic Pax3 and Pax7 function: implications for alveolar rhabdomyosarcoma cell of origin. Genes Dev. 2004, 18:2608-2613.
30. Kisanuki Y.Y., Hammer R.E., Miyazaki J., Williams S.C., Richardson J.A., Yanagisawa M. Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo. Dev. Biol. 2001, 230:230-242.
31. Kovacevic A., Hammer A., Stadelmeyer E., Windischhofer W., Sundl M., Ray A., Schweighofer N., Friedl G., Windhager R., Sattler W., Malle E. Expression of serum amyloid A transcripts in human bone tissues, differentiated osteoblast-like stem cells and human osteosarcoma cell lines. J. Cell. Biochem. 2008, 103:994-1004.
32. Leung C., Lingbeek M., Shakhova O., Liu J., Tanger E., Saremaslani P., Van Lohuizen M., Marino S. Bmi1 is essential for cerebellar development and is overexpressed in human medulloblastomas. Nature 2004, 428:337-341.
33. Logan M., Martin J.F., Nagy A., Lobe C., Olson E.N., Tabin C.J. Expression of Cre Recombinase in the developing mouse limb bud driven by a Prxl enhancer. Genesis 2002, 33:77-80.
34. Lyle P.L., Amato C.M., Fitzpatrick J.E., Robinson W.A. Gastrointestinal melanoma or clear cell sarcoma? Molecular evaluation of 7 cases previously diagnosed as malignant melanoma. Am. J. Surg. Pathol. 2008, 32:858-866.
35. Mangham D.C., Williams A., Lalam R.K., Brundler M.A., Leahy M.G., Cool W.P. Angiomatoid fibrous histiocytoma of bone: a calcifying sclerosing variant mimicking osteosarcoma. Am. J. Surg. Pathol. 2010, 34:279-285.
36. Mao X., Fujiwara Y., Orkin S.H. Improved reporter strain for monitoring Cre recombinase-mediated DNA excisions in mice. Proc. Natl. Acad. Sci. USA 1999, 96:5037-5042.
37. Méndez-Ferrer S., Michurina T.V., Ferraro F., Mazloom A.R., Macarthur B.D., Lira S.A., Scadden D.T., Ma'ayan A., Enikolopov G.N., Frenette P.S. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 2010, 466:829-834.
38. Murphy M.M., Lawson J.A., Mathew S.J., Hutcheson D.A., Kardon G. Satellite cells, connective tissue fibroblasts and their interactions are crucial for muscle regeneration. Development 2011, 138:3625-3637.
39. Muzumdar M.D., Tasic B., Miyamichi K., Li L., Luo L. A global double-fluorescent Cre reporter mouse. Genesis 2007, 45:593-605.
40. Nielsen T.O., West R.B., Linn S.C., Alter O., Knowling M.A., O'Connell J.X., Zhu S., Fero M., Sherlock G., Pollack J.R., et al. Molecular characterisation of soft tissue tumours: a gene expression study. Lancet 2002, 359:1301-1307.
41. Park I.K., Qian D., Kiel M., Becker M.W., Pihalja M., Weissman I.L., Morrison S.J., Clarke M.F. Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature 2003, 423:302-305.
42. Pérez-Losada J., Pintado B., Gutiérrez-Adán A., Flores T., Bañares-González B., del Campo J.C., Martín-Martín J.F., Battaner E., Sánchez-García I. The chimeric FUS/TLS-CHOP fusion protein specifically induces liposarcomas in transgenic mice. Oncogene 2000, 19:2413-2422.
43. Ren L., Guo S.P., Zhou X.G., Chan J.K. Angiomatoid fibrous histiocytoma: first report of primary pulmonary origin. Am. J. Surg. Pathol. 2009, 33:1570-1574.
44. Robson L.G., Di Foggia V., Radunovic A., Bird K., Zhang X., Marino S. Bmi1 is expressed in postnatal myogenic satellite cells, controls their maintenance and plays an essential role in repeated muscle regeneration. PLoS ONE 2011, 6:e27116.
45. Sangiorgi E., Capecchi M.R. Bmi1 is expressed in vivo in intestinal stem cells. Nat. Genet. 2008, 40:915-920.
46. Somers G.R., Viero S., Nathan P.C., Teshima I., Pereira C., Zielenska M. Association of the t(12;22)(q13;q12) EWS/ATF1 rearrangement with polyphenotypic round cell sarcoma of bone: a case report. Am. J. Surg. Pathol. 2005, 29:1673-1679.
47. Wang W.L., Mayordomo E., Zhang W., Hernandez V.S., Tuvin D., Garcia L., Lev D.C., Lazar A.J., Lopez-Terrada D. Detection and characterization of EWSR1/ATF1 and EWSR1/CREB1 chimeric transcripts in clear cell sarcoma (melanoma of soft parts). Mod. Pathol. 2009, 22:1201-1209.
48. Zhang H.W., Ding J., Jin J.L., Guo J., Liu J.N., Karaplis A., Goltzman D., Miao D. Defects in mesenchymal stem cell self-renewal and cell fate determination lead to an osteopenic phenotype in Bmi-1 null mice. J. Bone Miner. Res. 2010, 25:640-652.